Previous Article | Next Article ![]()
Infection and Immunity, September 1999, p. 4732-4736, Vol. 67, No. 9
The Evans Memorial Department of Clinical
Research and the Department of Medicine, Boston University School
of Medicine, Boston, Massachusetts 02118
Received 28 April 1999/Returned for modification 10 June
1999/Accepted 22 June 1999
Penicillium marneffei, a dimorphic fungus endemic in
parts of Asia, causes disease in those with impaired cell-mediated
immunity, especially persons with AIDS. The histopathology of
penicilliosis marneffei features the intracellular infection of
macrophages. We studied the interactions between human leukocytes and
heat-killed yeast-phase P. marneffei. Monocyte-derived
macrophages bound and internalized P. marneffei in the
presence of complement-sufficient pooled human serum (PHS). Binding and
phagocytosis were still seen if PHS was heat inactivated or omitted
altogether. The binding of unopsonized P. marneffei to
monocyte-derived macrophages occurred in the absence of divalent
cations and was not affected by inhibitors of mannose and Penicillium marneffei is
a dimorphic fungal pathogen endemic in southeast Asia, south China, and
Hong Kong. Prior to the AIDS epidemic, cases of penicilliosis marneffei
were limited to scattered case reports. However, with the spread of
human immunodeficiency virus (HIV) into regions where P. marneffei is endemic, the number of cases of penicilliosis
marneffei has increased greatly. For example, over a 7-year period,
1,115 cases of penicilliosis marneffei were seen in human
immunodeficiency virus-infected patients at the Chiang Mai University
Hospital in northern Thailand (44). There, penicilliosis
marneffei is the third most common opportunistic infection after
tuberculosis and cryptococcosis (45). Fever, anemia, weight
loss, lymphadenopathy, hepatomegaly, and skin lesions are relatively
common clinical manifestations, and mortality is substantial if the
infection is not treated in a timely fashion (45, 46). As
with many other AIDS-related opportunistic infections, even if initial
therapy is successful, lifetime prophylaxis of penicilliosis marneffei
is required to prevent relapse (46).
Infection with P. marneffei is presumed to originate in the
lung following the inhalation of airborne conidia. The recognition of
laminin by P. marneffei conidia may facilitate attachment to the bronchoalveolar epithelium (12). In susceptible hosts,
the fungus undergoes phase transition and reproduces as yeast cells. The histopathology of penicilliosis marneffei is characterized by the
intracellular infection of macrophages (9). Yeast cells of
P. marneffei measure approximately 2 to 3 by 2 to 7 µm and reproduce inside the macrophage by schizogony (9). In AIDS patients, the fungal burden usually is high, and intracellular P. marneffei organisms are readily seen in infected tissue
specimens. In murine models of penicilliosis marneffei, T cells are
critical for protection. Athymic mice are hypersusceptible to
infection, and partial protection can be adoptively transferred via
nylon wool nonadherent splenocytes (21). In immunocompetent
mice inoculated intranasally with P. marneffei, an
exuberant CD4+ T-cell infiltration into the lungs is
observed (22). Presumably then, analogous to many other
intracellular infections (23), the activation of macrophages
by T cell-derived cytokines is necessary to control penicilliosis
marneffei. In the present study, the interactions of human peripheral
blood mononuclear cells (PBMC) and monocyte-derived macrophages (MDM)
with P. marneffei were examined.
Materials.
Unless otherwise noted, reagents were
purchased from Sigma Chemical Co. (St. Louis, Mo.). Monoclonal
antibodies OKM10 and IB4 were gifts from Patricia Rao (Ortho
Pharmaceutical Corp., Raritan, N.J.) and Samuel Wright (Merck
Pharmaceutical, Rahway, N.J.), respectively. Monoclonal antibody MY4
was purchased from Coulter Immunology (Hialeah, Fla.). OKM10 reacts
with the complement binding site of the Fungi.
P. marneffei 30 was obtained from William
G. Merz (Johns Hopkins Medical Institute) and cultured in brain heart
infusion broth for 7 to 21 days at 37°C to obtain yeast-phase
organisms. A previously described strain of Candida albicans
(29) was grown in the yeast phase for 48 h on Sabouraud
dextrose agar. Fungi were heat killed (60°C for 30 min) and washed
six times in PBS. P. marneffei organisms were
surface labeled with rhodamine isothiocyanate (RITC) by incubation in a
1-mg/ml solution of RITC dissolved in 50 mM borate buffer, pH 8.0, for
18 h at 4°C (27). Fungi were washed extensively in
PBS prior to addition to phagocytes.
Isolation of PBMC and MDM.
Peripheral blood was obtained by
venipuncture from healthy adult volunteers. For each set of
experiments, the same donor was not used more than once. Blood was
anticoagulated with pyrogen-free heparin (Elkins-Sinn Inc., Cherry
Hill, N.J.) and centrifuged at 500 × g for 15 min. The
buffy coat was collected, and PBMC were purified by centrifugation on a
Ficoll-Hypaque density gradient as in previous studies (25,
26). MDM were obtained by incubating PBMC (2 × 105/well) in 96-well flat-bottom polystyrene tissue culture
plates with RPMI 1640 containing 10% male AB serum. Plates were
incubated at 37°C with 5% CO2 in a humidified chamber,
washed after 24 h to remove nonadherent cells, and cultured for an
additional 5 to 8 days.
Binding and internalization assays.
Wells containing MDM
were washed three times with RPMI 1640 warmed to 37°C. P. marneffei yeast cells (5 × 104/well)
were added and left in the wells for 60 min. To facilitate the
microscopic identification of fungi, RITC-labeled P. marneffei organisms were utilized (27). In
preliminary experiments, labeling did not affect binding. At the end of
incubation, unattached fungi were washed free and the cells were fixed
with 1% formaldehyde buffered in PBS. Wells were read with an
inverted microscope under epifluorescence. The binding index was
calculated as the number of cell-associated yeasts per 100 MDM. When
putative inhibitors and monoclonal antibodies were utilized, they were
added for 30 min prior to the addition of P. marneffei organisms. The percent inhibition of binding was
calculated by the following equation: [1
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Interactions of Penicillium marneffei
with Human Leukocytes In Vitro
and
![]()
ABSTRACT
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
-glucan
receptors or monoclonal antibodies directed against CD14 and CD11/CD18.
Binding was profoundly inhibited by wheat germ agglutinin. A vigorous
respiratory burst was seen in peripheral blood mononuclear cells (PBMC)
stimulated with P. marneffei, regardless of whether the
fungi were opsonized. However, tumor necrosis factor alpha (TNF-
)
release from PBMC stimulated with P. marneffei occurred
only if serum was present. These data demonstrate that (i)
monocyte-derived macrophages bind and phagocytose P. marneffei even in the absence of opsonization, (ii) binding is divalent cation independent but is inhibited by wheat germ agglutinin, suggesting that the major receptor(s) recognizing P. marneffei is a glycoprotein with exposed
N-acetyl-
-D-glucosaminyl groups, (iii)
P. marneffei stimulates the respiratory burst regardless of
whether opsonins are present, and (iv) serum factors are required for
P. marneffei to stimulate TNF-
release. The ability of
unopsonized P. marneffei to parasitize mononuclear
phagocytes without stimulating the production of TNF-
may be
critical for the virulence of this intracellular parasite.
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
![]()
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
chain of CD11b/CD18, IB4
reacts with the common
chain of the CD11/CD18 complex, and MY4
reacts with the lipopolysaccharide (LPS) receptor CD14 (50,
51). RPMI 1640 and phosphate-buffered saline (PBS) were obtained
from BioWhittaker, Inc. (Walkersville, Md.). Pooled human serum (PHS)
was obtained by combining sera from more than 10 healthy donors under
ice-cold conditions and storing it in aliquots at
70°C to preserve
complement activity. Supplemented PBS was PBS containing 1 g of
glucose per liter, 100 mg of CaCl2 per liter, and 100 mg of
MgCl2 per liter. All experiments were performed under
conditions carefully designed to minimize endotoxin contamination as
described (28). Except where otherwise indicated,
incubations were performed at 37°C in humidified air supplemented
with 5% CO2.
(binding index of
studied group/binding index of control)] × 100.
Hydrogen peroxide generation and TNF-
release.
Levels of
H2O2 production by stimulated PBMC were
measured by the H2O2-dependent, horseradish
peroxidase-mediated oxidation of homovanillic acid to the
fluorescent dimer 2,2'-dihydroxy-3,3'-dimethoxydiphenyl-5,5'-diacetic acid (14, 41). PBMC (2 × 106/well) were
added to 24-well flat-bottom plates and left unstimulated or
challenged with P. marneffei organisms and zymosan
(107 particles/well) for 2 h in supplemented PBS
containing homovanillic acid and horseradish peroxidase. The
fluorescence of the supernatants was compared with standards containing
known amounts of H2O2. Tumor necrosis factor
alpha (TNF-
) release was measured by enzyme-linked immunosorbent
assay as previously described (28, 29). For both the
H2O2 and TNF-
assays, PBMC were not washed
free of nonadherent cells prior to stimulation.
Statistics. Means and standard errors of the mean (SEM) were compared by using the two-tailed unpaired t test (SigmaStat Statistical Software; Jandel Corporation, San Rafael, Calif.). The Bonferroni correction was used to adjust for multiple comparisons. Statistical significance was considered to be achieved only if the P value multiplied by the number of comparisons was less than 0.05.
| |
RESULTS |
|---|
|
|
|---|
Binding and internalization. MDM were challenged with P. marneffei organisms in the presence of PHS, heat-inactivated PHS (HI-PHS), or no serum, and binding levels were assayed (Fig. 1). Regardless of opsonic conditions, MDM bound P. marneffei. However, optimal binding required complement-sufficient serum. Thus, in the presence of PHS approximately two and three times as many organisms bound to MDM as with HI-PHS and no serum, respectively. However, once bound, approximately 80% of the fungi subsequently were internalized, regardless of opsonic conditions.
|
Receptors involved in MDM binding of unopsonized P. marneffei organisms.
Having established that MDM bound
unopsonized P. marneffei organisms, we next sought to
determine the responsible receptor(s). Agents serving as competitive
ligands of
-glucan, mannose, and
-integrin receptors had no
effect on binding (Table 1). In addition, binding was not affected significantly by the presence of EDTA, indicating that divalent cations were not necessary. Dextran sulfate, which binds to macrophage scavenger receptors (38),
significantly inhibited binding by 32.9%. However, two other agents
that serve as ligands for scavenger receptors, heparin and fucoidin,
did not significantly inhibit binding once the Bonferroni correction was made.
|
chain of the CD18 complex,
and the LPS receptor CD14 failed to significantly inhibit binding
(Table 1). These three receptors are involved in the binding of other
unopsonized fungi (36, 37).
The lectin wheat germ agglutinin (WGA) profoundly inhibited P. marneffei binding to MDM in a dose-dependent fashion, with nearly 90% inhibition seen at the highest concentration used (Fig. 2). The inhibition of binding was
reversed by the addition of N-acetylglucosamine (NAG), a
preferred ligand for WGA. NAG by itself had no effect on binding
(inhibition, 0.0% ± 13.4%). The lectin concanavalin A, used at a
concentration of 100 µg/ml, also did not inhibit binding (inhibition,
35.8% ± 9.6%).
|
Stimulation of the respiratory burst. The ability of P. marneffei to stimulate the respiratory burst of PBMC, measured by H2O2 generation, was examined next (Fig. 3). P. marneffei vigorously stimulated PBMC H2O2 production, with about equal quantities seen in the presence of PHS and HI-PHS. In the absence of serum, stimulated H2O2 production was reduced modestly (by approximately 25%) but significantly (P < 0.001). The amounts of H2O2 generated were similar for PBMC stimulated by P. marneffei and by zymosan particles, the latter being a potent stimulus of monocyte H2O2 release (41).
|
Stimulation of TNF-
release.
In the final set of
experiments, the level of fungal stimulation of TNF-
production was
determined (Fig. 4). P. marneffei stimulated TNF-
release in the presence of PHS
and HI-PHS at all four ratios of P. marneffei
organisms to PBMC tested. Levels were comparable to that seen with 10 ng of LPS per ml, although less than that seen with heat-killed
C. albicans opsonized with PHS. When serum was omitted from
the system, P. marneffei and LPS failed to stimulate
significant amounts of TNF-
. In contrast, C. albicans
stimulated similar amounts of TNF-
in the presence of HI-PHS
compared with no serum.
|
| |
DISCUSSION |
|---|
|
|
|---|
Whether a microorganism is able to establish itself as a pathogen depends to a large extent upon which receptors on the host cells bind to it and upon the consequences of that binding (27). Only a paucity of immunological research has been performed on P. marneffei, and studies examining the mechanisms by which this medically important fungus gains access to macrophages have not previously been reported. The data presented here establish that P. marneffei binds to and is phagocytosed by human mononuclear phagocytes. While binding occurred in the absence of opsonins, it was enhanced approximately threefold by the presence of complement-sufficient PHS. In contrast, binding was not enhanced significantly if the PHS was heat inactivated under conditions which prevent activation of the complement system (19). Thus, P. marneffei can gain access to macrophages even in the absence of serum, but binding is enhanced by the presence of a serum factor(s), most likely complement.
P. marneffei reacts with a monoclonal antibody specific
for galactomannan; however, binding occurs on the plasma membrane and
not the outer surface of the fungal cell wall (39). In
contrast, a mannoprotein, designated MP1, reportedly is exposed on the
cell wall of P. marneffei (6). Nevertheless,
mannose receptors do not appear to be responsible for the binding
interaction of unopsonized P. marneffei organisms to
MDM, as yeast mannans, the mannosylated protein ovalbumin, and the
mannose-binding lectin concanavalin A all failed to inhibit binding.
Similarly, blocking
-glucan receptors had no significant effect on
P. marneffei binding to MDM. Mannose and
-glucan
receptors have been implicated in the interactions of C. albicans and Aspergillus fumigatus with macrophages (7, 16, 17, 31).
Monoclonal antibodies directed at the CD11/CD18
2-integrin complex
and CD14 also had no effect on the binding of unopsonized P. marneffei to MDM. CD11/CD18 is responsible for macrophage
binding of unopsonized Histoplasma capsulatum, whereas both
CD11b/CD18 and CD14 have been implicated in macrophage binding of
Blastomyces dermatitidis (36, 37). CD11b/CD18
also is a receptor for complement and
-glucan, whereas CD14
recognizes LPS and other microbial components (27, 40,
47). Lack of inhibition of binding by antireceptor
monoclonal antibodies does not rule out a role for the receptor in
binding, as the antibody could be recognizing an epitope distinct
from the fungal binding site. Further evidence against a role for
CD11/CD18 and other members of the
-integrin family is the lack
of inhibition by fibronectin and EDTA (10, 11, 42). The
-integrin receptors are divalent cation dependent.
Macrophage scavenger receptors bind a broad array of polyanionic ligands including surface components of gram-negative and gram-positive bacteria as well as the intact bacteria themselves (13, 20, 38). The anionic polysaccharides dextran sulfate and fucoidin as well as heparin inhibit at least some of the scavenger receptors (38). We observed a modest, but significant, inhibition of P. marneffei binding to MDM by using dextran sulfate and a trend towards significant inhibition with fucoidin. Thus, scavenger receptors might participate in macrophage binding of P. marneffei; however, these receptors do not appear to be the predominant ones responsible for binding.
WGA is a lectin with affinity for
N-acetyl-
-D-glucosaminyl residues and
N-acetyl-
-D-glucosamine oligomers
(34). Our finding that WGA treatment of MDM profoundly
inhibited the binding of unopsonized P. marneffei
organisms strongly suggests that the major receptor(s) recognizing this
fungus is a glycoprotein with exposed
N-acetyl-
-D-glucosaminyl groups. While many
cell surface glycoproteins on macrophages bind WGA (8, 43),
the functions of only a few are defined (2). Treatment of
macrophages with WGA has also been reported to inhibit the binding of
other particulate stimuli including iron beads (18) and
Leishmania mexicana mexicana promastigotes (3).
Like many other lectins, WGA stimulates macrophages (8).
However, the inhibition of fungal binding observed with WGA is unlikely
to be due to a nonspecific activation of the cells because another
lectin that stimulates macrophages, concanavalin A, did not inhibit binding.
Following the binding of P. marneffei to MDM, approximately 80% of the yeast cells were phagocytosed within 1 h. Phagocytosis proceeded regardless of the presence of opsonins. In this regard, the MDM response to P. marneffei is similar to that seen with H. capsulatum (36) but is different from the situation with encapsulated Cryptococcus neoformans, where most bound organisms are not readily phagocytosed even if opsonized with normal human serum (27).
A major mechanism by which phagocytes exhibit antimicrobial activity is oxidative killing, a process whereby molecular oxygen is reduced to form reactive oxygen products (33). Some intracellular pathogens have evolved mechanisms to escape killing by macrophages either by inhibiting production of oxygen metabolites or by neutralizing the metabolites that are produced (32, 33, 49). We found that P. marneffei potently stimulated H2O2 production by PBMC and that such stimulation was seen even in the absence of opsonization. Future studies are needed to determine whether the amounts of oxidants generated are sufficient to kill P. marneffei. Compared with bacteria, many fungi are relatively resistant to oxidants generated by phagocytes (24).
In addition to their role as effector cells capable of inhibiting and
killing microorganisms, mononuclear phagocytes secrete a variety of
bioactive substances that serve to modulate the inflammatory response
(35). One such substance is TNF-
, a proinflammatory cytokine that has a broad spectrum of immunoregulatory, metabolic, and
inflammatory activities (28, 48). TNF-
promotes
inflammation, possibly through the induction of cell adhesion
molecules, neutrophil and macrophage chemotactic factors, and acute
phase proteins and the generation of other proinflammatory cytokines
such as interleukin 1 and interleukin 6. We found that P. marneffei stimulated human PBMC to secrete TNF-
, in amounts
comparable to that stimulated by 10 ng of LPS per ml, provided that
serum was present. Thus, despite stimulating a vigorous respiratory
burst, unopsonized P. marneffei organisms failed to
stimulate TNF-
secretion. In animal models of fungal infection,
TNF-
is critical for host defenses (1, 15, 30). Thus, it
is tempting to speculate that the ability of unopsonized P. marneffei organisms to parasitize mononuclear phagocytes
without stimulating the production of TNF-
may enhance the virulence
of this intracellular parasite. Moreover, while incubation with HI-PHS
did not significantly increase the binding of P. marneffei to MDM, it did dramatically increase TNF-
secretion in PBMC. This suggests that heat-stable serum factors (such
as antibody or mannose-binding lectin) on the surface of P. marneffei are interacting with their corresponding leukocyte receptors to stimulate TNF-
production.
In many respects, macrophage interactions with P. marneffei are quite similar to that seen with H. capsulatum. Yeast cells from both species are bound and phagocytosed in the absence of opsonins and both stimulate a respiratory burst (5, 36). Similarly, the pathophysiology and clinical presentation of histoplasmosis and penicilliosis marneffei share overlapping features including the parasitism of macrophages (4, 9). However, clearly there are differences, most notably in the mechanisms by which the two fungi gain access to the macrophage. H. capsulatum entry into macrophages is divalent cation dependent and uses the CD18 complex (5, 36), whereas P. marneffei is divalent cation independent and gains access through a WGA-inhibitable process.
The data presented herein begin to define the events leading to the parasitism of macrophages by P. marneffei. However, many unanswered questions remain, including the definition of the specific receptor(s) responsible for binding and the conditions necessary to activate the macrophage to inhibit and kill P. marneffei. As the human immunodeficiency virus epidemic continues to spread in regions of Asia where P. marneffei is endemic, the incidence of penicilliosis marneffei is likely to increase. Insights into the mechanisms whereby the immune system responds to infection by P. marneffei could lead to novel approaches to prevention and therapy of this medically important fungus. Moreover, the study of the interactions between macrophages and P. marneffei could serve to increase our general understanding of the mechanisms of intracellular parasitism.
| |
ACKNOWLEDGMENTS |
|---|
This work was supported by grants AI37532 and AI25780 from the National Institutes of Health. S.M.L. is the recipient of a Burroughs Wellcome Fund Scholar Award in Pathogenic Mycology.
We thank Patricia Rao and Samuel Wright for the generous gifts of antibodies and William G. Merz for providing the P. marneffei strain as well as helpful advice on growing the fungus.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Room E336, Boston Medical Center, 88 E. Newton St., Boston, MA 02118. Phone: (617) 638-7904. Fax: (617) 638-8070. E-mail: slevitz{at}bu.edu.
Present address: Division of Infectious Diseases, Department of
Internal Medicine, Faculty of Medicine, Siriraj Hospital, Mahidol
University, Bangkoknoi, Bangkok 10700, Thailand.
Editor: T. R. Kozel
| |
REFERENCES |
|---|
|
|
|---|
| 1. |
Allendoerfer, R., and G. S. Deepe, Jr.
1998.
Blockade of endogenous TNF-alpha exacerbates primary and secondary pulmonary histoplasmosis by differential mechanisms.
J. Immunol.
160:6072-6082 |
| 2. |
Basu, M.,
J. L. Pace,
D. M. Pinson,
M. P. Hayes,
P. P. Trotta, and S. W. Russell.
1988.
Purification and partial characterization of a receptor protein for mouse interferon gamma.
Proc. Natl. Acad. Sci. USA
85:6282-6286 |
| 3. | Bray, R. S. 1983. Leishmania mexicana mexicana: attachment and uptake of promastigotes to and by macrophages in vitro. J. Protozool. 30:314-322[Medline]. |
| 4. | Bullock, W. E. 1995. Histoplasma capsulatum, p. 2340-2353. In G. L. Mandell, J. E. Bennet, and R. Dolin (ed.), Mandell, Douglas and Bennett's principles and practice of infectious diseases, 4th ed. Churchill Livingstone Inc., New York, N.Y. |
| 5. |
Bullock, W. E., and S. D. Wright.
1987.
Role of the adherence-promoting receptors, CR3, LFA-1, and p150,95, in binding of Histoplasma capsulatum by human macrophages.
J. Exp. Med.
165:195-210 |
| 6. |
Cao, L.,
C. M. Chan,
C. Lee,
S. S. Wong, and K. Y. Yuen.
1998.
MP1 encodes an abundant and highly antigenic cell wall mannoprotein in the pathogenic fungus Penicillium marneffei.
Infect. Immun.
66:966-973 |
| 7. |
Castro, M.,
N. V. C. Ralston,
T. I. Morgenthaler,
M. S. Rohrbach, and A. H. Limper.
1994.
Candida albicans stimulates arachidonic acid liberation from alveolar macrophages through -mannan and -glucan cell wall components.
Infect. Immun.
62:3138-3145 |
| 8. |
Christiansen, N. P., and K. M. Skubitz.
1988.
Identification of the major lectin-binding surface proteins of human neutrophils and alveolar macrophages.
Blood
71:1624-1632 |
| 9. | Cooper, C. R., Jr., and M. R. McGinnis. 1997. Pathology of Penicillium marneffei. An emerging acquired immunodeficiency syndrome-related pathogen. Arch. Pathol. Lab. Med. 121:798-804[Medline]. |
| 10. |
Gailit, J., and E. Ruoslahti.
1988.
Regulation of the fibronectin receptor affinity by divalent cations.
J. Biol. Chem.
263:12927-12932 |
| 11. |
Griggs, D. W.,
C. M. Schmidt, and C. P. Carron.
1998.
Characteristics of cation binding to the I domains of LFA-1 and MAC-1. The LFA-1 domain contains a Ca2+-binding site.
J. Biol. Chem.
273:22113-22119 |
| 12. |
Hamilton, A. J.,
L. Jeavons,
S. Youngchim,
N. Vanittanakom, and R. J. Hay.
1998.
Sialic acid-dependent recognition of laminin by Penicillium marneffei conidia.
Infect. Immun.
66:6024-6026 |
| 13. | Hampton, R. Y., D. T. Golenbock, M. Penman, M. Krieger, and C. R. Raetz. 1991. Recognition and plasma clearance of endotoxin by scavenger receptors. Nature 352:342-344[Medline]. |
| 14. | Harrison, T. S., and S. M. Levitz. 1997. Mechanisms of impaired anticryptococcal activity of monocytes from donors infected with human immunodeficiency virus. J. Infect. Dis. 176:537-540[Medline]. |
| 15. | Huffnagle, G. B., G. B. Toews, M. D. Burdick, M. B. Boyd, K. S. McAllister, R. A. McDonald, S. L. Kunkel, and R. M. Strieter. 1996. Afferent phase production of TNF-alpha is required for the development of protective T cell immunity to Cryptococcus neoformans. J. Immunol. 157:4529-4536[Abstract]. |
| 16. | Kan, V. L., and J. E. Bennett. 1991. Beta 1,4-oligoglucosides inhibit the binding of Aspergillus fumigatus conidia to human monocytes. J. Infect. Dis. 163:1154-1156[Medline]. |
| 17. | Kan, V. L., and J. E. Bennett. 1988. Lectin-like attachment sites on murine pulmonary alveolar macrophages bind Aspergillus fumigatus conidia. J. Infect. Dis. 158:407-414[Medline]. |
| 18. | Kouzan, S., J. E. Gallagher, T. Eling, and A. R. Brody. 1985. Binding of iron beads to sialic acid residues on macrophage membranes stimulates arachidonic acid metabolism. Lab. Investig. 53:320-327[Medline]. |
| 19. | Kozel, T. R. 1996. Activation of the complement system by pathogenic fungi. Clin. Microbiol. Rev. 9:34-46[Abstract]. |
| 20. | Krieger, M. 1997. The other side of scavenger receptors: pattern recognition for host defense. Curr. Opin. Lipidol. 8:275-280[Medline]. |
| 21. | Kudeken, N., K. Kawakami, N. Kusano, and A. Saito. 1996. Cell-mediated immunity in host resistance against infection caused by Penicillium marneffei. J. Med. Vet. Mycol. 34:371-378[Medline]. |
| 22. | Kudeken, N., K. Kawakami, and A. Saito. 1997. CD4+ T cell-mediated fatal hyperinflammatory reactions in mice infected with Penicillium marneffei. Clin. Exp. Immunol. 107:468-473[Medline]. |
| 23. | Levitz, S. M. 1992. Overview of host defenses in fungal infections. Clin. Infect. Dis. 14:S37-S42. |
| 24. | Levitz, S. M., and R. D. Diamond. 1985. Mechanisms of resistance of Aspergillus fumigatus conidia to killing by neutrophils in vitro. J. Infect. Dis. 152:33-42[Medline]. |
| 25. |
Levitz, S. M., and T. P. Farrell.
1990.
Growth inhibition of Cryptococcus neoformans by cultured human monocytes: role of the capsule, opsonins, the culture surface, and cytokines.
Infect. Immun.
58:1201-1209 |
| 26. | Levitz, S. M., and T. P. Farrell. 1990. Human neutrophil degranulation stimulated by Aspergillus fumigatus. J. Leukoc. Biol. 47:170-175[Abstract]. |
| 27. | Levitz, S. M., and A. Tabuni. 1991. Binding of Cryptococcus neoformans by human cultured macrophages. Requirements for multiple complement receptors and actin. J. Clin. Investig. 87:528-535. |
| 28. |
Levitz, S. M.,
A. Tabuni,
H. Kornfeld,
C. C. Reardon, and D. T. Golenbock.
1994.
Production of tumor necrosis factor alpha in human leukocytes stimulated by Cryptococcus neoformans.
Infect. Immun.
62:1975-1981 |
| 29. | Levitz, S. M., A. Tabuni, S.-H. Nong, and D. T. Golenbock. 1996. Effects of interleukin-10 on human peripheral blood mononuclear cell responses to Cryptococcus neoformans, Candida albicans, and lipopolysaccharide. Infect. Immun. 64:945-951[Abstract]. |
| 30. |
Louie, A.,
A. L. Baltch,
R. P. Smith,
M. A. Franke,
W. J. Ritz,
J. K. Singh, and M. A. Gordon.
1994.
Tumor necrosis factor alpha has a protective role in a murine model of systemic candidiasis.
Infect. Immun.
62:2761-2772 |
| 31. | Marodi, L., S. Schreiber, D. C. Anderson, R. P. MacDermott, H. M. Korchak, and R. B. Johnson, Jr. 1993. Enhancement of macrophage candidacidal activity by interferon-gamma. Increased phagocytosis, killing, and calcium signal mediated by a decreased number of mannose receptors. J. Clin. Investig. 91:2596-2601. |
| 32. | Mor, N., M. B. Goren, and M. J. Pabst. 1988. Mycobacterium lepraemurium activates macrophages but fails to trigger release of superoxide anion. J. Immunol. 140:3956-3961[Abstract]. |
| 33. | Murray, H. W. 1988. Survival of intracellular pathogens within human mononuclear phagocytes. Semin. Hematol. 25:101-111[Medline]. |
| 34. |
Nagata, Y., and M. M. Burger.
1974.
Wheat germ agglutinin. Molecular characteristics and specificity for sugar binding.
J. Biol. Chem.
249:3116-3122 |
| 35. | Nathan, C. F. 1987. Secretory products of macrophages. J. Clin. Investig. 79:319-326. |
| 36. | Newman, S. L., C. Bucher, J. Rhodes, and W. E. Bullock. 1990. Phagocytosis of Histoplasma capsulatum yeasts and microconidia by human cultured macrophages and alveolar macrophages. Cellular cytoskeleton requirement for attachment and ingestion. J. Clin. Investig. 85:223-230. |
| 37. | Newman, S. L., S. Chaturvedi, and B. S. Klein. 1995. The WI-1 antigen of Blastomyces dermatitidis yeasts mediates binding to human macrophage CD11b/CD18 (CR3) and CD14. J. Immunol. 154:753-761[Abstract]. |
| 38. | Pearson, A. M. 1996. Scavenger receptors in innate immunity. Curr. Opin. Immunol. 8:20-28[Medline]. |
| 39. | Pierard, G. E., J. Arrese Estrada, C. Pierard-Franchimont, A. Thiry, and D. Stynen. 1991. Immunohistochemical expression of galactomannan in the cytoplasm of phagocytic cells during invasive aspergillosis. Am. J. Clin. Pathol. 96:373-376[Medline]. |
| 40. | Pugin, J., I. D. Heumann, A. Tomasz, V. V. Kravchenko, Y. Akamatsu, M. Nishijima, M. P. Glauser, P. S. Tobias, and R. J. Ulevitch. 1994. CD14 is a pattern recognition receptor. Immunity 1:509-516[Medline]. |
| 41. | Ruch, W., P. H. Cooper, and M. Baggiolini. 1983. Assay of H2O2 production by macrophages and neutrophils with homovanillic acid and horseradish peroxidase. J. Immunol. Methods 63:347-357[Medline]. |
| 42. | Ruoslahti, E. 1988. Fibronectin and its receptors. Annu. Rev. Biochem. 57:375-413[Medline]. |
| 43. | Satoh, M., and M. Yamazaki. 1987. Glycoprotein receptors to wheat germ agglutinin on the surface of murine macrophages. J. Pharmacobio-Dyn. 10:608-615[Medline]. |
| 44. | Sirisanthana, T., K. Supparatpinyo, J. Perriens, and K. E. Nelson. 1998. Amphotericin B and itraconazole for treatment of disseminated Penicillium marneffei infection in human immunodeficiency virus-infected patients. Clin. Infect. Dis. 26:1107-1110[Medline]. |
| 45. | Supparatpinyo, K., C. Khamwan, V. Baosoung, K. E. Nelson, and T. Sirisanthana. 1994. Disseminated Penicillium marneffei infection in southeast Asia. Lancet 344:110-113[Medline]. |
| 46. |
Supparatpinyo, K.,
J. Perriens,
K. E. Nelson, and T. Sirisanthana.
1998.
A controlled trial of itraconazole to prevent relapse of Penicillium marneffei infection in patients infected with the human immunodeficiency virus.
N. Engl. J. Med.
339:1739-1743 |
| 47. | Vetvicka, V., B. P. Thornton, and G. D. Ross. 1996. Soluble beta-glucan polysaccharide binding to the lectin site of neutrophil or natural killer cell complement receptor type 3 (CD11b/CD18) generates a primed state of the receptor capable of mediating cytotoxicity of iC3b-opsonized target cells. J. Clin. Investig. 98:50-61[Medline]. |
| 48. |
Vilcek, J., and T. H. Lee.
1991.
Tumor necrosis factor. New insights into the molecular mechanisms of its multiple actions.
J. Biol. Chem.
266:7313-7316 |
| 49. |
Wilson, C. B.,
V. Tsai, and J. S. Remington.
1980.
Failure to trigger the oxidative metabolic burst by normal macrophages: possible mechanism for survival of intracellular pathogens.
J. Exp. Med.
151:328-346 |
| 50. |
Wright, S. D.,
R. A. Ramos,
P. S. Tobias,
R. J. Ulevitch, and J. C. Mathison.
1990.
CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein.
Science
249:1431-1433 |
| 51. |
Wright, S. D.,
P. E. Rao,
W. C. Van Voorhis,
L. S. Craigmyle,
K. Iida,
M. A. Talle,
E. F. Westberg,
G. Goldstein, and S. C. Silverstein.
1983.
Identification of the C3bi receptor of human monocytes and macrophages by using monoclonal antibodies.
Proc. Natl. Acad. Sci. USA
80:5699-5703 |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»